Skip to main content
. Author manuscript; available in PMC: 2010 Aug 11.
Published in final edited form as: Nature. 2008 Nov 12;456(7222):663–666. doi: 10.1038/nature07483

Figure 4.

Figure 4

Pax2 predicts clinical outcome in breast cancer patients. Kaplan-Meier curve representing percent relapse free survival in tumours based on Pax2 and AIB-1 staining (n = 109). The percentage of ErbB2 over-expressing tumours within each category is provided.